Simvastatin 40mg: Clinical Trials

10 trials of Simvastatin 40mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 recruiting, 2 unknown, 1 active not recruiting. 10 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 4, Recruiting 3, Unknown 2, Active not recruiting 1
Phase 11Unknown 1
Phase 31Recruiting 1

Follow Simvastatin 40mg: new trials by email Literature Review of Simvastatin 40mg trials Research Report on Simvastatin 40mg

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
Simvastatin 40mg - Prostate Cancer
Phase 2RecruitingMedical University of South Carolina362024-03-112026-03-04
The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer
Simvastatin 40mg, Placebo - Triple Negative Breast Cancer, Chemotherapy Effect
Phase 2RecruitingUniversitas Indonesia262022-08-192026-09-21
Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Simvastatin 40mg - Liver Fibrosis, Alcohol Abuse
Phase 2 / Phase 3RecruitingAnna Cruceta902022-02-222024-12-04
Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
Irinotecan, Simvastatin - Small Cell Lung Cancer
Phase 2UnknownShanghai Pulmonary Hospital, Shanghai, China402021-11-012021-08-09
Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression
Simvastatin 40mg, Placebo oral tablet - Depressive Disorder, Major, Obesity
Phase 2CompletedCharite University, Berlin, Germany1612020-08-132024-12-09
Effects of Simvastatin on Uterine Leiomyoma Size
Simvastatin 40mg, Placebo 40 mg - Fibroid Uterus, Fibroid Tumor
Phase 2Active not recruitingJohns Hopkins University602018-08-202026-07-21
Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin
Simvastatin 40mg - Sickle Cell Disease, Stroke
Phase 1 / Phase 2UnknownUniversity of Campinas, Brazil282018-03-052020-10-12
Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer
Simvastatin 40mg, Placebo oral capsule - Breast Cancer, Chemotherapy Effect
Phase 2CompletedUniversitas Indonesia602018-01-152020-06-05
Simvastatin Plus Rifaximin in Decompensated Cirrhosis
Simvastatin 20 mg, Simvastatin 40mg, Rifaximin 400 mg - Cirrhoses, Liver
Phase 2CompletedJudit Pich442017-07-262019-03-28
Simvastatin in Uveitis
Simvastatin 40mg - Uveitis
Phase 2CompletedFederal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology502014-09-012019-12-03

Conditions studied

Alcoholism (1)  ·  Anemia, Sickle Cell (1)  ·  Breast Neoplasms (1)  ·  Depressive Disorder, Major (1)  ·  Leiomyoma (1)  ·  Liver Cirrhosis (1)  ·  Margins of Excision (1)  ·  Obesity (1)  ·  Prostatic Neoplasms (1)  ·  Small Cell Lung Carcinoma (1)  ·  Stroke (1)  ·  Triple Negative Breast Neoplasms (1)  ·  Uveitis (1)

Sponsors

Universitas Indonesia (2)  ·  Anna Cruceta (1)  ·  Charite University, Berlin, Germany (1)  ·  Federal State Budgetary Scientific Institution, Research Institute of Fundamental and Clinical Immunology (1)  ·  Johns Hopkins University (1)  ·  Judit Pich (1)  ·  Medical University of South Carolina (1)  ·  Shanghai Pulmonary Hospital, Shanghai, China (1)  ·  University of Campinas, Brazil (1)

Countries

Germany (2)  ·  Indonesia (2)  ·  Spain (2)  ·  United States (2)  ·  Brazil (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Russia (1)  ·  United Kingdom (1)

Top investigators

Baju Adji (1)  ·  Bruno Benites, MD (1)  ·  Christian Otte, MD (1)  ·  Erwin D Yulian, MD (1)  ·  Filipus Dasawala, MD (1)  ·  Hanifah Hasan, MD (1)  ·  Michael Marrone, PhD (1)  ·  Mostafa Borahay, MD, PhD (1)  ·  Muhammad Rizki Kamil, MD (1)  ·  Nurjati Chairani Siregar, MD (1)  ·  Pere Gines, Md (1)  ·  Shabrina Adzania, MD (1)  ·  Tantri Hellyanti, MD (1)

Results publications

PMID 12467231, PMID 16170339, PMID 30641276, PMID 31607677, PMID 32346071, PMID 32377822, PMID 33262189, PMID 33285097, PMID 38043603, PMID 40465256, PMID 40824526

NIH funding

2016 (1), R01HD094380 (1)